Casamba EVV vs Pfizer C4951086
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Casamba EVV
Read full descriptionHide full description
Electronic Visit Verification (EVV) for HealthWyse Home.
Pfizer C4951086
Read full descriptionHide full description
The Pfizer eCOA App is intended for use to collect participants reported outcomes relating to the C4951086 clinical trial. In order to log into the app, Participants must be given accounts by the site
Screenshots
Verdict
The clearest difference is update cadence: Pfizer C4951086 at every 2 weeks against Casamba EVV's every 2 months. Casamba EVV's advantage is iOS requirement (12.0 vs 17.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Casamba EVV ships an update every 2 months, Pfizer C4951086 every 2 weeks. The most recent releases landed on October 27, 2026 and October 25, 2026 respectively.
| Parameter | Casamba EVV | Pfizer C4951086 |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 2 months | Every 2 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 12.0 — better | 17.0 |
| Further details — not scored | ||
| Size | 45 MB | 109 MB |
| Age rating | 12+ | 12+ |
| Developer | HealthWyse, A Casamba Company | ERT, INC |
In-app purchases
Casamba EVV
No in-app purchases
Pfizer C4951086
No in-app purchases
